Dr. Irene Malaty, from the University of Florida, discusses how to identify patients who may benefit from Vyalev (foscarbidopa/foslevodopa), highlighting key indicators that a patient is ready to transition beyond oral levodopa therapy. She reviews the impact of motor fluctuations, medication burden, and absorption challenges, and explains how continuous subcutaneous levodopa de...
Subscribe in seconds and receive Innovations in Clinical Neuroscience's news feed updates in your inbox, on your phone or even read them from your own news page here on follow.it.
You can select the updates using tags or topics and you can add as many websites to your feed as you like.
And the service is entirely free!
Follow Innovations in Clinical Neuroscience: ICNS Home - Innovations in Clinical Neuroscience